Review
Open access
Aug 2026
Targeted immunotherapies for anaplastic lymphoma kinase-positive pediatric tumors: current advances and future perspectives
AlK-specific immunotherapies, including ALK vaccines, ALK CAR-T and other cellular therapies, as well as ALK-targeting antibodies with a particular focus on pediatric ALK-positive tumors are discussed.
Monica Maccagno, Roberta Tagliero, Roberto Chiarle et al.
· Frontiers in Immunology · 0 citations